依达拉奉针联合丁苯肽注射液治疗急性脑梗塞疗效观察

目的:探讨急性脑梗塞采用依达拉奉联合丁苯酞治疗的临床疗效。方法:研究将2015年2月~2018年2月收治的90例急性脑梗塞患者随机分为两组,A组采用依达拉奉治疗,B组在A组治疗基础上结合丁苯酞治疗,比较两组的疗效差异。结果:两组治疗前NIHSS评分、CRP、Hcy水平比较无明显差异(P>0.05);B组治疗后上述指标均明显低于A组,治疗总有效率明显高于A组,差异有统计学意义(P<0.05)。结论:丁苯酞联合依达拉奉治疗急性脑梗塞,有利于神经功能恢复,可降低患者的炎症水平,能预防血栓形成。

Clinical Observation of Edaravone Combined with Butadiene Styrene Injection in Treatment of Acute Cerebral Infarction

Objective:To discuss the clinical efficacy of edaravone combined with butadiene styrene injection in the treatment of acute cerebral infarction. Methods:90 patients with acute cerebral infarction from February 2015 to February 2018 were randomly divided into two groups. Edaravone was used in group A, and butadiene styrene injection was used in group B on the basis of group A. The therapeutic effects of the two groups were compared. Results: There was no significant difference in NIHSS score, CRP and Hcy between the two groups before treatment(P>0.05). The above indexes in group B were significantly lower than those in group A, and the total effective rate was significantly higher than that in group A, with significant difference(P<0.05). Conclusion:Butadiene styrene injection combined with edaravone in the treatment of acute cerebral infarction is conducive to the recovery of nerve function, it can reduce the level of inflammation in patients and prevent thrombosis.